Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019
A widely-criticized meta-analysis led to town halls and FDA advisory meetings, with no resolution of the mortality signal.
Related Articles
SCAI Renal Denervation Regional Course—Houston 2025 | SCAI
High blood pressure is a leading risk factor for heart disease and stroke, affecting nearly half of US adults and contributing to 685,875 deaths in…
Accreditation | SCAI
As part of our mission to lead the global interventional cardiovascular community in quality patient care, SCAI has partnered with Corazon, Inc. as our preferred…
SCAI Signals Concerns About NIH Research Formula | SCAI
SCAI recently joined physician and medical research organizations in a letter to NIH highlighting concerns about the recently announced policy imposing a 15% cap on…
Point-of-Care App | SCAI
A free resource that the entire cardiovascular care team can use in the Cath Lab and clinic to quickly and easily refer to our clinical…
Use PCI Risk Scores to Assess Risks of Peri-procedural Complications! | SCAI
Home Use PCI Risk Scores to Assess Risks of Peri-procedural Complications! By: Faisal Latif, MD, FSCAI, Suresh Mulukutla, MD, and Jacob A. Doll, MD, FSCAI…
Heart Valve Disease Awareness Day – Heart Valve Disease Awareness Day
Increasing recognition of the specific risks and symptoms of heart valve disease
Congenital Heart Disease
Congenital heart disease (CHD) is a heart birth defect present at birth and is when something in the heart doesn’t form properly in the fetus…
PAD Pulse Alliance Urges Screening for Disease Most Don’t Know They Have During American Heart Month | SCAI
Today, one disease affects 10 million Americans and is the most common cause of limb amputation outside of trauma. Yet, 70% of Americans don’t know…
Medical imaging trends to watch in 2025
The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025.